---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-020321"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2021-10-21T23:59:59+00:00"
generated_at: "2026-06-28T19:24:07.923746+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology annual meeting results: all proposals approved by shareholders

## Summary
- All seven director nominees elected; Scott R. Tobin received highest support (8,518,378 votes).
- EisnerAmper LLP ratified as independent auditor for FY2022 (8,762,596 for, 326 against).
- Non-binding advisory vote on named executive officer compensation passed (8,531,715 for, 103,135 against).
- 2021 Equity Incentive Plan approved by stockholders (7,451,194 for, 1,211,189 against).

## SEC filing metadata
- accession: 0001628280-21-020321
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2021-10-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828021020321/0001628280-21-020321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828021020321/csbr-20211020.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-020321
- JSON: https://secwatch.observer/filing/0001628280-21-020321.json
- Plain text: https://secwatch.observer/filing/0001628280-21-020321.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.